Carmen Ghilardi

5PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 04, 2025
Stroma gene signature predicts responsiveness to chemotherapy in pancreatic ductal adenocarcinoma patient-derived xenograft models.

Alessia Anastasia, Laura Formenti, Paola Ostano

|Aug 04, 2023
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.

Massimo Russo, Nicolò Panini, Paola Fabbrizio

|Mar 30, 2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.

Giulia Dellavedova, Alessandra Decio, Laura Formenti

|Feb 12, 2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.

Alessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya

|Feb 08, 2022
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.

Carmen Ghilardi, Catarina Moreira-Barbosa, Laura Brunelli

Pageof 1

Frequent Collaborators

4 joint publications

MariaRosa Bani

3 joint publications

Laura Formenti

3 joint publications

Massimo Russo

2 joint publications

Alessia Anastasia